- Home
- MEDP vs CHRW Comparison
MEDP vs CHRW Comparison
Compare MEDP & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- CHRW
- Stock Information
- Founded
- MEDP 1992
- CHRW 1905
- Country
- MEDP United States
- CHRW United States
- Employees
- MEDP N/A
- CHRW N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- CHRW Oil Refining/Marketing
- Sector
- MEDP Health Care
- CHRW Consumer Discretionary
- Exchange
- MEDP Nasdaq
- CHRW Nasdaq
- Market Cap
- MEDP 10.5B
- CHRW 11.6B
- IPO Year
- MEDP 2016
- CHRW 1997
- Fundamental
- Price
- MEDP $287.85
- CHRW $92.23
- Analyst Decision
- MEDP Buy
- CHRW Buy
- Analyst Count
- MEDP 10
- CHRW 19
- Target Price
- MEDP $373.22
- CHRW $119.29
- AVG Volume (30 Days)
- MEDP 428.9K
- CHRW 1.6M
- Earning Date
- MEDP 04-21-2025
- CHRW 04-30-2025
- Dividend Yield
- MEDP N/A
- CHRW 2.62%
- EPS Growth
- MEDP 42.23
- CHRW 41.91
- EPS
- MEDP 12.63
- CHRW 3.86
- Revenue
- MEDP $2,109,054,000.00
- CHRW $17,724,956,000.00
- Revenue This Year
- MEDP $4.45
- CHRW $2.25
- Revenue Next Year
- MEDP $9.67
- CHRW $4.65
- P/E Ratio
- MEDP $24.08
- CHRW $24.55
- Revenue Growth
- MEDP 11.84
- CHRW 0.73
- 52 Week Low
- MEDP $289.01
- CHRW $65.00
- 52 Week High
- MEDP $459.77
- CHRW $114.82
- Technical
- Relative Strength Index (RSI)
- MEDP 32.73
- CHRW 32.97
- Support Level
- MEDP $295.22
- CHRW $100.63
- Resistance Level
- MEDP $311.99
- CHRW $103.00
- Average True Range (ATR)
- MEDP 10.53
- CHRW 2.22
- MACD
- MEDP -2.32
- CHRW -0.55
- Stochastic Oscillator
- MEDP 8.41
- CHRW 4.41
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 61% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (27%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.